Health
Improve our lives while reducing societal costs
Health is at the heart of our daily concerns, and preserving a good quality of life for everyone, at a controlled cost to society, is a major challenge for the coming decades throughout the world. Living longer must go hand in hand with a demand for a higher quality of life, from a health point of view, but solutions can only be implemented if they are economically acceptable to society.
What are the biggest challenges in this sector for the next decade ?
Among the many challenges facing the healthcare sector, several seem to us to be particularly important for the coming decades:
- The fight against cancer, which is responsible for 1 in 6 deaths worldwide and is the leading cause of death. The ageing of the population is likely to exacerbate this phenomenon.
- The fight against silent diseases, which have a real impact on patients’ quality of life and life expectancy (type II diabetes).
- Preserving mental health, which affects 25% of the European population, with real impacts on quality of life and the ability of patients to participate fully in the country’s activities.
- Reducing the cost of care, thanks to innovative solutions that provide better care (e.g. chronic wounds)
Why we believe deeptech can solve the biggest challenges ?
Almost all major innovations in the healthcare sector are the result of academic research, so it is natural to try to optimise the transfer rate between this research and applications in human health. The development of multi-disciplinary teams (chemistry, biology, physics) and collaborations between these teams and clinicians is making it possible to significantly increase the number and quality of technological assets developed within French academic laboratories.
What kind of project do we want to create there ?
We are looking for projects with the potential to have a wide-ranging environmental, social and economic impact. Here are a few examples of topics that have caught our attention:
- Development of therapeutic solutions to treat cancers that are resistant to current therapies
- Medical devices that can drastically improve patients’ quality of life at no or low cost to society
- Mass diagnostic technologies for earlier detection of the most common pathologies, but which have a major impact on patient life expectancy if detected too late